Answers are grounded in this paper and cite their sources.
The cost-effectiveness of work-site hypertension programs was examined at three manufacturing plants. A fourth plant was used as a control site to estimate expected levels of hypertension control from screening without further intervention. The annual cost per hypertensive employee of the three intervention programs was $26.26 for semiannual follow-up, $35 for full follow-up, and $96.19 for on-site treatment. Each intervention resulted in an additional 1% of hypertensive employees maintained under control, per dollar spent annually, with the highest cost per unit of effectiveness being incurred for free on-site treatment. Cost-effectiveness may vary considerably, however, depending on the additional costs a company may incur as a result of program adoption.
No takes yet. Share an insight, caveat, or question.
Erfurt et al. (1984) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: